Parker AS - Search Results

1

Genome-wide association study identifies multiple risk loci for renal cell carcinoma.

Scelo G, Purdue MP, Brown KM, Johansson M, Wang Z, Eckel-Passow JE, Ye Y, Hofmann JN, Choi J, Foll M, Gaborieau V, Machiela MJ, Colli LM, Li P, Sampson JN, Abedi-Ardekani B, Besse C, Blanche H, Boland A, Burdette L, Chabrier A, Durand G, Le Calvez-Kelm F, Prokhortchouk E, Robinot N, Skryabin KG, Wozniak MB, Yeager M, Basta-Jovanovic G, Dzamic Z, Foretova L, Holcatova I, Janout V, Mates D, Mukeriya A, Rascu S, Zaridze D, Bencko V, Cybulski C, Fabianova E, Jinga V, Lissowska J, Lubinski J, Navratilova M, Rudnai P, Szeszenia-Dabrowska N, Benhamou S, Cancel-Tassin G, Cussenot O, Baglietto L, Boeing H, Khaw KT, Weiderpass E, Ljungberg B, Sitaram RT, Bruinsma F, Jordan SJ, Severi G, Winship I, Hveem K, Vatten LJ, Fletcher T, Koppova K, Larsson SC, Wolk A, Banks RE, Selby PJ, Easton DF, Pharoah P, Andreotti G, Freeman LEB, Koutros S, Albanes D, Männistö S, Weinstein S, Clark PE, Edwards TL, Lipworth L, Gapstur SM, Stevens VL, Carol H, Freedman ML, Pomerantz MM, Cho E, Kraft P, Preston MA, Wilson KM, Michael Gaziano J, Sesso HD, Black A, Freedman ND, Huang WY, Anema JG, Kahnoski RJ, Lane BR, Noyes SL, Petillo D, Teh BT, Peters U, White E, Anderson GL, Johnson L, Luo J, Buring J, Lee IM, C… See abstract for full author list ➔ Scelo G, et al. Among authors: parker as. Nat Commun. 2017 Jun 9;8:15724. doi: 10.1038/ncomms15724. Nat Commun. 2017. PMID: 28598434 Free PMC article.

2

Prediction of progression after radical nephrectomy for patients with clear cell renal cell carcinoma: a stratification tool for prospective clinical trials.

Leibovich BC, Blute ML, Cheville JC, Lohse CM, Frank I, Kwon ED, Weaver AL, Parker AS, Zincke H. Leibovich BC, et al. Among authors: parker as. Cancer. 2003 Apr 1;97(7):1663-71. doi: 10.1002/cncr.11234. Cancer. 2003. PMID: 12655523 Free article.

3

History of urinary tract infection and risk of renal cell carcinoma.

Parker AS, Cerhan JR, Lynch CF, Leibovich BC, Cantor KP. Parker AS, et al. Am J Epidemiol. 2004 Jan 1;159(1):42-8. doi: 10.1093/aje/kwh014. Am J Epidemiol. 2004. PMID: 14693658

4

Loss of expression of von Hippel-Lindau tumor suppressor protein associated with improved survival in patients with early-stage clear cell renal cell carcinoma.

Parker AS, Cheville JC, Lohse CM, Igel T, Leibovich BC, Blute ML. Parker AS, et al. Urology. 2005 Jun;65(6):1090-5. doi: 10.1016/j.urology.2004.12.040. Urology. 2005. PMID: 15893810

5

Clear cell renal cell carcinoma: gene expression analyses identify a potential signature for tumor aggressiveness.

Kosari F, Parker AS, Kube DM, Lohse CM, Leibovich BC, Blute ML, Cheville JC, Vasmatzis G. Kosari F, et al. Among authors: parker as. Clin Cancer Res. 2005 Jul 15;11(14):5128-39. doi: 10.1158/1078-0432.CCR-05-0073. Clin Cancer Res. 2005. PMID: 16033827

6

Tumor B7-H1 is associated with poor prognosis in renal cell carcinoma patients with long-term follow-up.

Thompson RH, Kuntz SM, Leibovich BC, Dong H, Lohse CM, Webster WS, Sengupta S, Frank I, Parker AS, Zincke H, Blute ML, Sebo TJ, Cheville JC, Kwon ED. Thompson RH, et al. Among authors: parker as. Cancer Res. 2006 Apr 1;66(7):3381-5. doi: 10.1158/0008-5472.CAN-05-4303. Cancer Res. 2006. PMID: 16585157

7

High expression levels of survivin protein independently predict a poor outcome for patients who undergo surgery for clear cell renal cell carcinoma.

Parker AS, Kosari F, Lohse CM, Houston Thompson R, Kwon ED, Murphy L, Riehle DL, Blute ML, Leibovich BC, Vasmatzis G, Cheville JC. Parker AS, et al. Cancer. 2006 Jul 1;107(1):37-45. doi: 10.1002/cncr.21952. Cancer. 2006. PMID: 16736510 Free article.

8

Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.

Parker AS, Lohse CM, Cheville JC, Thiel DD, Leibovich BC, Blute ML. Parker AS, et al. Urology. 2006 Oct;68(4):741-6. doi: 10.1016/j.urology.2006.05.024. Urology. 2006. PMID: 17070345

9

Survivin and b7-h1 are collaborative predictors of survival and represent potential therapeutic targets for patients with renal cell carcinoma.

Krambeck AE, Dong H, Thompson RH, Kuntz SM, Lohse CM, Leibovich BC, Blute ML, Sebo TJ, Cheville JC, Parker AS, Kwon ED. Krambeck AE, et al. Among authors: parker as. Clin Cancer Res. 2007 Mar 15;13(6):1749-56. doi: 10.1158/1078-0432.CCR-06-2129. Clin Cancer Res. 2007. PMID: 17363528

10

Alcohol intake and renal cell cancer in a pooled analysis of 12 prospective studies.

Lee JE, Hunter DJ, Spiegelman D, Adami HO, Albanes D, Bernstein L, van den Brandt PA, Buring JE, Cho E, Folsom AR, Freudenheim JL, Giovannucci E, Graham S, Horn-Ross PL, Leitzmann MF, McCullough ML, Miller AB, Parker AS, Rodriguez C, Rohan TE, Schatzkin A, Schouten LJ, Virtanen M, Willett WC, Wolk A, Zhang SM, Smith-Warner SA. Lee JE, et al. Among authors: parker as. J Natl Cancer Inst. 2007 May 16;99(10):801-10. doi: 10.1093/jnci/djk181. J Natl Cancer Inst. 2007. PMID: 17505075

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

198 results

Search Page